Search results
Armour-plating your portfolio: Explore the potential of defence stocks and ETFs
Livemint· 6 days agoThanks to factors like heightened competitive intensity, overcapacity and rapid technological...
Bansal Wire IPO: From financials to key risks, here are 10 key things to know from RHP before...
Livemint· 3 days agoBansal Wire IPO initial Public offer that is open for subscription now, started on 3, July 2024 and closes on 5, July, 2024. The bidding range for the Bansal Wire IPO is ₹243 to ₹256 per < ...
Discount brokerage firms feel the heat
Financial Express· 4 days agoShares of discount broking firms fell sharply on Tuesday after the Securities and Exchange Board of India (Sebi) came out with guidelines that market...
Namita Thapar-backed Emcure Pharma IPO kicks off: Should you subscribe to the issue?
Business Today· 4 days agoThe initial public offering (IPO) of Emcure Pharmaceuticals opens for bidding on Wednesday, July 3...
Emcure Pharmaceuticals IPO fully subscribed on Day 1. Check GMP and other details
The Economic Times· 4 days agoThe initial public offer (IPO) of Emcure Pharmaceuticals, which opened earlier today, was booked...
Substantial profit booking in coming weeks can't be ruled out, pick these 3 largecaps, says Jigar...
CNBC Awaaz· 7 days agoThe FIIs long-short ratio in index futures reached over 80 percent, the highest in months. This...
Multibagger Shilchar Technologies soars 11550% in 4 years, 577% in last 1 year; should you buy? |...
Livemint· 3 days agoMultiagger stock Shilchar Technologies has emerged as a top performer for long-term investors,...
Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid?
The Economic Times· 4 days agoAhead of the issue opening, the company raised Rs 582 crore from anchor investors. Marquee investors...
Rs 807 to Rs 2,474: This defence stock turned into a multibagger in three months; hit record high...
Business Today· 5 days agoShares of Garden Reach Shipbuilders have tripled investors’ wealth in the last three months. The...
Emcure Pharmaceuticals IPO booked nearly 5x so far on Day 2. Check GMP and other details
The Economic Times· 3 days agoThe initial public offer (IPO) of Emcure Pharmaceuticals was booked nearly five times so far on...